Literature DB >> 24778216

Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation.

Chen-Lin Hsieh1, Teng Fei2, Yiwen Chen3, Tiantian Li1, Yanfei Gao4, Xiaodong Wang1, Tong Sun1, Christopher J Sweeney1, Gwo-Shu Mary Lee1, Shaoyong Chen4, Steven P Balk4, Xiaole Shirley Liu3, Myles Brown2, Philip W Kantoff5.   

Abstract

The androgen receptor (AR) is a key factor that regulates the behavior and fate of prostate cancer cells. The AR-regulated network is activated when AR binds enhancer elements and modulates specific enhancer-promoter looping. Kallikrein-related peptidase 3 (KLK3), which codes for prostate-specific antigen (PSA), is a well-known AR-regulated gene and its upstream enhancers produce bidirectional enhancer RNAs (eRNAs), termed KLK3e. Here, we demonstrate that KLK3e facilitates the spatial interaction of the KLK3 enhancer and the KLK2 promoter and enhances long-distance KLK2 transcriptional activation. KLK3e carries the core enhancer element derived from the androgen response element III (ARE III), which is required for the interaction of AR and Mediator 1 (Med1). Furthermore, we show that KLK3e processes RNA-dependent enhancer activity depending on the integrity of core enhancer elements. The transcription of KLK3e was detectable and its expression is significantly correlated with KLK3 (R(2) = 0.6213, P < 5 × 10(-11)) and KLK2 (R(2) = 0.5893, P < 5 × 10(-10)) in human prostate tissues. Interestingly, RNAi silencing of KLK3e resulted in a modest negative effect on prostate cancer cell proliferation. Accordingly, we report that an androgen-induced eRNA scaffolds the AR-associated protein complex that modulates chromosomal architecture and selectively enhances AR-dependent gene expression.

Entities:  

Keywords:  KLK3e/AR/Med1 complex; chromosomal looping

Mesh:

Substances:

Year:  2014        PMID: 24778216      PMCID: PMC4034202          DOI: 10.1073/pnas.1324151111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth.

Authors:  Zhong Chen; Chunpeng Zhang; Dayong Wu; Hongyan Chen; Anna Rorick; Xiaoting Zhang; Qianben Wang
Journal:  EMBO J       Date:  2011-05-10       Impact factor: 11.598

2.  Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions.

Authors:  Ci Chu; Kun Qu; Franklin L Zhong; Steven E Artandi; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-29       Impact factor: 17.970

3.  Long noncoding RNAs with enhancer-like function in human cells.

Authors:  Ulf Andersson Ørom; Thomas Derrien; Malte Beringer; Kiranmai Gumireddy; Alessandro Gardini; Giovanni Bussotti; Fan Lai; Matthias Zytnicki; Cedric Notredame; Qihong Huang; Roderic Guigo; Ramin Shiekhattar
Journal:  Cell       Date:  2010-10-01       Impact factor: 41.582

Review 4.  Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer.

Authors:  Karen E Knudsen; Trevor M Penning
Journal:  Trends Endocrinol Metab       Date:  2010-02-06       Impact factor: 12.015

5.  A large fraction of extragenic RNA pol II transcription sites overlap enhancers.

Authors:  Francesca De Santa; Iros Barozzi; Flore Mietton; Serena Ghisletti; Sara Polletti; Betsabeh Khoramian Tusi; Heiko Muller; Jiannis Ragoussis; Chia-Lin Wei; Gioacchino Natoli
Journal:  PLoS Biol       Date:  2010-05-11       Impact factor: 8.029

6.  Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus.

Authors:  Mitchell G Lawrence; John Lai; Judith A Clements
Journal:  Endocr Rev       Date:  2010-01-26       Impact factor: 19.871

7.  The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis.

Authors:  Charles E Massie; Andy Lynch; Antonio Ramos-Montoya; Joan Boren; Rory Stark; Ladan Fazli; Anne Warren; Helen Scott; Basetti Madhu; Naomi Sharma; Helene Bon; Vinny Zecchini; Donna-Michelle Smith; Gina M Denicola; Nik Mathews; Michelle Osborne; James Hadfield; Stewart Macarthur; Boris Adryan; Scott K Lyons; Kevin M Brindle; John Griffiths; Martin E Gleave; Paul S Rennie; David E Neal; Ian G Mills
Journal:  EMBO J       Date:  2011-05-20       Impact factor: 11.598

8.  Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression.

Authors:  John R Prensner; Matthew K Iyer; O Alejandro Balbin; Saravana M Dhanasekaran; Qi Cao; J Chad Brenner; Bharathi Laxman; Irfan A Asangani; Catherine S Grasso; Hal D Kominsky; Xuhong Cao; Xiaojun Jing; Xiaoju Wang; Javed Siddiqui; John T Wei; Daniel Robinson; Hari K Iyer; Nallasivam Palanisamy; Christopher A Maher; Arul M Chinnaiyan
Journal:  Nat Biotechnol       Date:  2011-07-31       Impact factor: 54.908

9.  Widespread transcription at neuronal activity-regulated enhancers.

Authors:  Tae-Kyung Kim; Martin Hemberg; Jesse M Gray; Allen M Costa; Daniel M Bear; Jing Wu; David A Harmin; Mike Laptewicz; Kellie Barbara-Haley; Scott Kuersten; Eirene Markenscoff-Papadimitriou; Dietmar Kuhl; Haruhiko Bito; Paul F Worley; Gabriel Kreiman; Michael E Greenberg
Journal:  Nature       Date:  2010-04-14       Impact factor: 49.962

10.  Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA.

Authors:  Dong Wang; Ivan Garcia-Bassets; Chris Benner; Wenbo Li; Xue Su; Yiming Zhou; Jinsong Qiu; Wen Liu; Minna U Kaikkonen; Kenneth A Ohgi; Christopher K Glass; Michael G Rosenfeld; Xiang-Dong Fu
Journal:  Nature       Date:  2011-05-15       Impact factor: 49.962

View more
  173 in total

Review 1.  Exploiting genomics and natural genetic variation to decode macrophage enhancers.

Authors:  Casey E Romanoski; Verena M Link; Sven Heinz; Christopher K Glass
Journal:  Trends Immunol       Date:  2015-08-19       Impact factor: 16.687

2.  RNA Binding to CBP Stimulates Histone Acetylation and Transcription.

Authors:  Daniel A Bose; Greg Donahue; Danny Reinberg; Ramin Shiekhattar; Roberto Bonasio; Shelley L Berger
Journal:  Cell       Date:  2017-01-12       Impact factor: 41.582

Review 3.  Architectural and Functional Commonalities between Enhancers and Promoters.

Authors:  Tae-Kyung Kim; Ramin Shiekhattar
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

4.  Enhancer RNA facilitates NELF release from immediate early genes.

Authors:  Katie Schaukowitch; Jae-Yeol Joo; Xihui Liu; Jonathan K Watts; Carlos Martinez; Tae-Kyung Kim
Journal:  Mol Cell       Date:  2014-09-25       Impact factor: 17.970

5.  Enhancer RNAs.

Authors:  Wenbo Li; Michael T Y Lam; Dimple Notani
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

6.  RNA transcribed from a distal enhancer is required for activating the chromatin at the promoter of the gonadotropin α-subunit gene.

Authors:  Lilach Pnueli; Sergei Rudnizky; Yahav Yosefzon; Philippa Melamed
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-25       Impact factor: 11.205

Review 7.  Chromatin loops and causality loops: the influence of RNA upon spatial nuclear architecture.

Authors:  Iain A Sawyer; Miroslav Dundr
Journal:  Chromosoma       Date:  2017-06-07       Impact factor: 4.316

8.  Fetal γ-globin genes are regulated by the BGLT3 long noncoding RNA locus.

Authors:  Maria Soledad Ivaldi; Luis Francisco Diaz; Lyubomira Chakalova; Jongjoo Lee; Ivan Krivega; Ann Dean
Journal:  Blood       Date:  2018-08-27       Impact factor: 22.113

9.  Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs.

Authors:  Nasun Hah; Chris Benner; Ling-Wa Chong; Ruth T Yu; Michael Downes; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-06       Impact factor: 11.205

10.  RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation.

Authors:  Homa Rahnamoun; Jihoon Lee; Zhengxi Sun; Hanbin Lu; Kristen M Ramsey; Elizabeth A Komives; Shannon M Lauberth
Journal:  Nat Struct Mol Biol       Date:  2018-08-03       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.